Date	Name	Title	Type	Shares Traded	Price Range
Dec 20, 2007	sanofi-aventis	Beneficial Owner (10% or more)	Statement of Ownership	0	n/a
Feb 15, 2008	baker charles a	Director	Automatic Sell	10,000	18.67 - 19.06
Feb 15, 2008	baker charles a	Director	Option Execute	10,000	7.91
Feb 20, 2009	baker charles a	Director	Automatic Sell	10,000	18.16
Feb 20, 2009	baker charles a	Director	Option Execute	10,000	7.66
Jun 2, 2010	baker charles a	Director	Option Execute	5,000	25.43
Nov 5, 2007	brown michael s	Director	Automatic Sell	13,292	20.31 - 20.66
Nov 5, 2007	brown michael s	Director	Option Execute	10,000	7.91
Nov 5, 2007	brown michael s	Director	Automatic Sell	600	20.67 - 20.87
Nov 6, 2007	brown michael s	Director	Automatic Sell	6,108	19.42 - 20.08
Jan 17, 2008	brown michael s	Director	Automatic Sell	200	25.00
Jan 22, 2008	brown michael s	Director	Automatic Sell	9,800	25.00
May 18, 2010	brown michael s	Director	Option Execute	5,000	25.43
Sep 9, 2008	brown michael s	Director	Option Execute	5,000	7.66
Feb 23, 2009	brown michael s	Director	Option Execute	5,000	7.66
Nov 2, 2009	brown michael s	Director	Disposition (Non Open Market)	12,000	n/a
Apr 9, 2010	brown michael s	Director	Acquisition (Non Open Market)	29,662	n/a
May 18, 2010	brown michael s	Director	Disposition (Non Open Market)	4,476	28.40
May 19, 2010	brown michael s	Director	Sell	524	27.73
Dec 12, 2007	gilman alfred g	Director	Disposition (Non Open Market)	2,000	n/a
Showing 1-20 of 174 transactions Page: 1 2 3 4 5 6 7 8 9  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.